Pilat M J, Schwab E D, Yao K L, Pienta K J
University of Michigan, Department of Internal Medicine, Ann Arbor 48109-0946, USA.
Anticancer Res. 1998 Jul-Aug;18(4A):2575-82.
Molecular changes in the progressive state of tumorigenesis often include altered patterns of DNA methylation. Utilizing a series of breast epithelial cell lines, the overall 5-methylcytosine content in genomic DNA demonstrated an overall decrease when comparing two malignant cell lines (MCF-7 and T47D) with a mortal cell line (MCF 1 2M) and several derivative cell lines of the immortalized MCF10 cultures (MCF10A,-2A, -5A, A1neoT2, and 139B6). Further investigation on the methylation status of these cells lines indicated no difference in DNA methyltransferase activity, both at a protein and mRNA levels, in the nontumorigenic cell lines examined while activity was 3-10 fold higher in the tumorigenic lines (MCF7, T47D, SkBr3, MB-MDA-231, -468). Examination of the CpG island in the 5' promoter region of the estrogen receptor gene indicates that this region is unmethylated in the mortal and immortal nontumorigenic lines as well as the tumorigenic lines examined, with the exception of the estrogen receptor negative breast cell line MB-MDA-468 which appears to be partially methylated at this site. These results indicate methylation of this CpG island does not account for the inactivation of the estrogen receptor gene in immortalized nontumorigenic breast cells, suggesting another mechanism of transcriptional inactivation of ER in this environment.
肿瘤发生进展状态下的分子变化通常包括DNA甲基化模式的改变。利用一系列乳腺上皮细胞系,与永生化前体细胞系(MCF 1 2M)以及永生化MCF10培养物的几个衍生细胞系(MCF10A、-2A、-5A、A1neoT2和139B6)相比,当比较两个恶性细胞系(MCF-7和T47D)时,基因组DNA中的整体5-甲基胞嘧啶含量呈现出总体下降。对这些细胞系甲基化状态的进一步研究表明,在所检测的非致瘤细胞系中,DNA甲基转移酶活性在蛋白质和mRNA水平上均无差异,而在致瘤细胞系(MCF7、T47D、SkBr3、MB-MDA-231、-468)中活性高3至10倍。对雌激素受体基因5'启动子区域的CpG岛进行检测表明,在永生化前体和非致瘤细胞系以及所检测的致瘤细胞系中,该区域均未甲基化,但雌激素受体阴性的乳腺细胞系MB-MDA-468除外,该细胞系在该位点似乎部分甲基化。这些结果表明,该CpG岛的甲基化并不能解释永生化非致瘤乳腺细胞中雌激素受体基因的失活,提示在这种环境下雌激素受体转录失活的另一种机制。